Preparing a submission for Cancer Gene Therapy
Cancer Gene Therapy sets its own submission rules: length and word limits, the required citation and reference style, figure and table formatting, and editorial policies. Scraiber tracks 27 requirements for Cancer Gene Therapy and rewrites your manuscript to meet each one.
Instead of checking each rule by hand, import your draft into Scraiber, select Cancer Gene Therapy, and let it rewrite your text to match: the exact word limits, reference style and structure, so your paper is submission-ready.
If the paper was rejected elsewhere, most of the work in retargeting Cancer Gene Therapy is mechanical: the reference style changes, headings and sections move, word and abstract limits differ, and the declarations have to follow Cancer Gene Therapy's own template. Scraiber applies those changes to the draft you already have instead of you rebuilding the manuscript by hand.
Manuscript types at Cancer Gene Therapy
Cancer Gene Therapy documents its author requirements per manuscript type: Brief Communication, Perspective, Research Article, Review Article. The rules differ between them, so Scraiber applies the set that matches the type you are submitting.
What Cancer Gene Therapy specifies
These are the areas Cancer Gene Therapy writes rules for. Scraiber holds the exact value behind each one and applies it to your draft.
- Length & word limits 5 rules: abstract word limit, page limit, reference limit, title character limit, word limit.
- Citations & references 2 rules: citation style, reference abbreviations.
- Figures 1 rule: display item limit.
- Formatting & submission 9 rules: author contributions, competing interests, contributor roles, cover letter, data availability, ethics statement, line spacing, manuscript format, units.
What Scraiber changes in your manuscript
Scraiber rewrites the parts of your draft that Cancer Gene Therapy constrains: it brings sections within the required lengths, converts in-text citations and the bibliography to the required style, adjusts headings and structure, and flags the declarations Cancer Gene Therapy expects. Your argument, results and voice stay yours — only what the journal dictates changes.
Frequently asked questions
- What are the submission requirements for Cancer Gene Therapy?
- Cancer Gene Therapy has 27 documented author requirements covering length limits, citation style, figures, tables and submission policies. Sign in to Scraiber to see each exact value and rewrite your manuscript to match.
- Which citation style does Cancer Gene Therapy use?
- Scraiber tracks Cancer Gene Therapy's required reference style and reformats your citations to it automatically. Open the journal in Scraiber to apply it to your document.
- Can I automatically format my paper for Cancer Gene Therapy?
- Yes. Paste or import your draft into Scraiber, pick Cancer Gene Therapy, and it rewrites your text to meet the journal's requirements: length, references, structure and more.
- How do I reformat a paper rejected by another journal for Cancer Gene Therapy?
- Import the manuscript you already submitted elsewhere, select Cancer Gene Therapy, and Scraiber rewrites it against Cancer Gene Therapy's requirements: reference style, length limits, structure and declarations. You never start from a blank page.
- How long does it take to prepare a manuscript for Cancer Gene Therapy?
- Minutes rather than an evening. The rewrite runs on your existing draft, so what disappears is the manual pass over every formatting rule.
- Does Cancer Gene Therapy have different requirements per manuscript type?
- Yes. Cancer Gene Therapy documents separate requirements per manuscript type. Pick your type in Scraiber and it applies that set to your document.
- Do I have to redo my references for Cancer Gene Therapy?
- No. Scraiber converts your existing citations and bibliography to the reference style Cancer Gene Therapy requires, including the in-text citation format.
Official author guidelines: nature.com